Scientists explore whether what heals the head can also heal the heart
What do heart disease and dementia have in common? Perhaps more than meets the eye, according to researchers at the University of Rochester Medical Center.
A diverse group of scientists experts in cardiology, neurology, immunology, microbiology and chemistry are teaming up to study drugs that show promise in the treatment of dementia for the treatment of an equally debilitating disease heart failure. In this case, the connection between the head and the heart lies in a particular enzyme that they believe plays a role in the development of both conditions.
The team, headed by Burns C. Blaxall, Ph.D., Harris A. "Handy" Gelbard, M.D., Ph.D., and Stephen Dewhurst, Ph.D., recently won the largest grant awarded to date by the University's Clinical and Translational Science Institute (CTSI) $250,000 over two years. The grant, part of the CTSI's newly initiated Incubator Program, is larger than most awarded by the Medical Center.
Thomas Pearson, M.D., Ph.D., who heads the CTSI and helped develop the new program, says tremendous weight was given to forming new teams that had never worked together before, and for these teams to study things they had never addressed before. The Blaxall/Gelbard/Dewhurst team fit the bill on both counts.
"The brain and the heart are two completely different systems that are rarely considered to have biological, or emotional, overlap," said Blaxall, lead researcher for the new study and an associate professor within the Aab Cardiovascular Research Institute at the Medical Center. "We may find that they are not so different after all."
The unique investigation stems from years of research by Gelbard, a neurologist, and Dewhurst, a microbiologist and immunologist, to develop the world's first treatment designed to prevent dementia commonly associated with HIV infection. They have already created a compound that shows great promise in the laboratory and works by blocking an enzyme known as MLK3, which plays a key role in the inflammatory process.
In patients with HIV-associated dementia, excess inflammation a byproduct of the body's natural attempt to protect itself from the virus damages healthy brain cells and leads to cognitive difficulties. Excess inflammation is also a hallmark of heart failure: Tissue damage from a heart attack, for example, ignites an inflammatory response to guide repair, but if the response is too strong, "inflammation overload" leads to scarring that hinders the heart's ability to pump blood throughout the body.
Given Gelbard and Dewhurst's understanding of MLK3, and Blaxall's expertise in the molecular mechanisms underlying heart failure, they joined forces to study if the enzyme plays a role in the disease. According to Gelbard, who heads the Center for Neural Development and Disease at the Medical Center, "This is a great example of how one area of research can really help inform another."
Their preliminary studies of cardiac cells suggest that, in fact, MLK3 is involved in the inflammation and scarring characteristic of heart failure. Even more exciting is research showing that a compound very similar to the MLK3 inhibitor in development for HIV-associated dementia slowed the progression of heart failure.
The Rochester team is working in close collaboration with Val S. Goodfellow, Ph.D., CEO of biotechnology company Califia Bio Inc., in the ongoing identification and development of a range of MLK3 inhibitor compounds.
"The idea that MLK3 inhibitors could have an impact in treating dementia, but also in treating heart failure, bridges very prevalent, very bad diseases that we need better treatments for," noted Randy N. Rosier, M.D., Ph.D., co-director of the Pilot and Collaborative Studies Key Function within the CTSI who, along with fellow co-director Richard T. Moxley, M.D., selected the Blaxall/Gelbard/Dewhurst team to receive the Incubator grant. "We are extremely enthusiastic about this collaboration and think it has great potential to bring in additional funding from outside the University and birth even bigger, longstanding research programs here."
In addition to attracting new funding, the Incubator Program represents an important investment in the University's future by involving students and young investigators in the translational research process. Blaxall's team, which also includes Sanjay B. Maggirwar, Ph.D., will mentor four trainees as part of the grant.
The study comes at a time when the general model for drug discovery and development is changing. As pharmaceutical companies reduce their investments in early-stage research, due to high costs and substantial risk, academic institutions like the Medical Center are playing an increasingly larger role.
According to Dewhurst, chair of the Department of Microbiology and Immunology, "Companies are looking to academia to come up with novel ideas and to test and "de-risk" them at an early phase and a lower cost." With the support of the CTSI, through the Incubator grant and a host of other funding programs, researchers at Rochester are poised and ready to take the reins.
As for the current research, Gelbard says that while HIV-associated dementia is a very important problem, and one that he's focused his entire career on, it is still a small part of the health care universe. "If our work ultimately leads to a potential therapy for heart failure the implications of that are far larger. That would be a wonderful piece of serendipity."
Provided by University of Rochester Medical Center
- Researchers target HIV-related brain difficulties Oct 07, 2010 | not rated yet | 0
- Researchers Race to Design the First Treatments Specifically for NeuroAIDS Oct 03, 2006 | not rated yet | 0
- Targeting flight-or-fight hormone response to combat heart failure Jun 24, 2010 | not rated yet | 0
- Researchers pinpoint patients who receive greatest benefit from heart failure treatment Mar 01, 2011 | not rated yet | 0
- New heart failure device is tested Oct 17, 2006 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
Nearly 20 percent of kidneys that are recovered from deceased donors in the U.S. are refused for transplant due to factors ranging from scarring in small blood vessels of the kidney's filtering units to the organ going too ...
Medical research 11 hours ago | 5 / 5 (2) | 0 |
Discovery of circadian clock in mice hair reveals period of time when damage from radiotherapy can be quickly repaired
Discovering that mouse hair has a circadian clock - a 24-hour cycle of growth followed by restorative repair - researchers suspect that hair loss in humans from toxic cancer radiotherapy and chemotherapy ...
Medical research 11 hours ago | 5 / 5 (2) | 1 |
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...
Medical research 12 hours ago | 4.8 / 5 (6) | 2 |
New research from the University of Southampton has shown that blind and visually impaired people have the potential to use echolocation, similar to that used by bats and dolphins, to determine the location of an object.
Medical research 15 hours ago | not rated yet | 1 |
A novel vaccine study from South Dakota State University (SDSU) will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference ...
Medical research 15 hours ago | not rated yet | 0
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
9 hours ago | 4.6 / 5 (12) | 4 |
Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital ...
3 hours ago | not rated yet | 0 |
New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...
12 hours ago | 4.8 / 5 (11) | 2 |
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
12 hours ago | 5 / 5 (3) | 0 |
Bacteria resistant to the antibiotic colistin are also commonly resistant to antimicrobial substances made by the human body, according to a study in mBio, the online open-access journal of the American Society for Microb ...
3 hours ago | 5 / 5 (1) | 0
Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...
10 hours ago | 3.3 / 5 (10) | 0 |